Dr. John Harrison

Full time consultant to major corporations developing fine chemical businesses, focusing on strategy development and implementation, technology assessment and business development with major life sciences customers. Ran Eastman Fine Chemicals $400M P&L; Responsible for Strategy Development and Implementation (1989-2000)

  • Vice President of R&D Sterling Organics, Division of Sterling Drug (now Rhodia-Chirex); Responsible for World-Wide Process Development & Scale Up of New Pharmaceuticals and Fine Chemicals (1964-1989)
  • BA and PhD Kings College Cambridge
  • Member of GrowthPhases ® Industry Expert Network